Polycystic ovary syndrome

Endocrinology and Metabolism Clinics of North America

Volumn 27, Issue 4, 1998, Pages 877-902

  Taylor, A E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETYNODIOL DIACETATE; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORGESTIMATE; FINASTERIDE; FLUTAMIDE; FOLLITROPIN; GLUCOSE; GONADORELIN AGONIST; HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE; METFORMIN; ORAL CONTRACEPTIVE AGENT; PRASTERONE SULFATE; SPIRONOLACTONE; THYROTROPIN; TROGLITAZONE;

AMENORRHEA; DRUG MIXTURE; ELECTROLYSIS; FEMALE; FEMALE INFERTILITY; GASTROINTESTINAL TOXICITY; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERKALEMIA; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LASER; LIVER TOXICITY; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW;

FALLOPIA;

EID: 0031701874     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70045-1     Document Type: Article

References (135)

1. J. Adams D.W. Polson S. Franks Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism BMJ (Clin Res) 293 1986 355
2. Abdel Gadir A. R.S. Mowafi H.M.I. Alnaser Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease Clin Endocrinol 33 1990 585 592
3. E.Y. Adashi A.J.W. Hseuh S.S.C. Yen Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells Endocrinology 108 1981 1441
4. Anttila L. Ding Y.-Q. K. Ruutiainen Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease Fertil Steril 55 1991 1057
5. R. Azziz D. Dewailly D. Owerbach Nonclassical adrenal hyperplasia: Current concepts J Clin Endocrinol Metab 78 1994 810
6. D.T. Baird C.S. Corker D.W. Davidson Pituitary-ovarian relationships in polycystic ovary syndrome J Clin Endocrinol Metab 45 1977 798
7. A.H. Balen S.L. Tan J. MacDougall Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin Hum Reprod 8 1993 959
8. R.L. Barbieri A. Makris K.J. Ryan Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca Obstet Gynecol 64 1984 735
9. R.B. Barnes R.L. Rosenfield S. Burstein Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome N Engl J Med 320 1989 559
10. S.L. Berga D.S. Guzick S.J. Winters Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation J Clin Endocrinol Metab 77 1993 895
11. M.J. Berger M.L. Taymor W.C. Patton Gonadotropin levels and secretory patterns in patients with typical and atypical polycystic ovarian disease Fertil Steril 26 1975 619
12. M.A. Birdsall C.M. Farquhar H.D. White Association between polycystic ovaries and coronary artery disease in women having cardiac catheterization Ann Intern Med 126 1997 32
13. J.A. Board S.M. Rosenberg J.S. Smeltzer Spironolactone and estrogen-progestin therapy for hirsutism South Med J 80 1987 43
14. H.M. Buckler M. Bangah D.L. Healy Vaginal progesterone administration in physiologic doses normalizes raised luteinizing hormone levels in patients with polycystic ovarian syndrome Gynecol Endocrinol 6 1992 275 282
15. C.W. Burger T. Korsen van Kessel H. Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea J Clin Endocrinol Metab 61 1985 1126
16. G.A. Burghen J.R. Givens A.E. Kitabchi Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease J Clin Endocrinol Metab 50 1980 113
17. Burkman R.T. Jr The role of oral contraceptives in the treatment of hyperandrogenic disorders Am J Med 98 suppl 1A 1995 130S
18. Castelo-Branco C. Martinez de Osaba M.J. F. Pons Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: Effects on hair, bone, and hormone profile after 1-year use Metabolism 46 1997 437
19. R.J. Chang L.R. Laufer D.R. Meldrum Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist J Clin Endocrinol Metab 56 1983 897
20. R.J. Chang F.P. Mandel J.K.H. Lu Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease J Clin Endocrinol Metab 54 1982 490
21. R.J. Chang R.M. Nakamura H.L. Judd Insulin resistance in nonobese patients with polycystic ovary syndrome J Clin Endocrinol Metab 57 1983 356
22. G.M. Christman J.F. Randolph R.P. Kelch Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease J Clin Endocrinol Metab 72 1991 1278
23. T.P. Ciaraldi A. El-Roeiy Z. Madar Cellular mechanisms of insulin resistance in polycystic ovarian syndrome J Clin Endocrinol Metab 75 1992 577
24. L. Ciotta A. Cianci E. Marletta Treatment of hirsutism with flutamide and a low-dose oral contraceptive in polycystic ovarian disease patients Fertil Steril 62 1994 1129
25. G.S. Conway J.W. Honour H.S. Jacobs Heterogeneity of the polycystic ovary syndrome: Clinical, endocrine, and ultrasound features in 556 patients Clin Endocrinol 30 1989 459
26. Corenthal L. Von Hagen S. D. Larkins Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome Fertil Steril 61 1994 1027
27. C.B. Coulam J.F. Anneger J.S. Kranz Chronic anovulation syndrome and associated neoplasia Obstet Gynecol 61 1983 403
28. Couzinet B. Le Strat N. S. Brailly Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease J Clin Endocrinol Metab 63 1986 1031
29. D.C. Cumming J.C. Yang R.W. Rebar Treatment of hirsutism with spironolactone JAMA 247 1982 1295
30. L. Cusan A. Dupont Gomez J.-L. Comparison of flutamide and spironolactone in the treatment of hirsutism: A randomized controlled trial Fertil Steril 61 1994 281
31. E. Dahlgren S. Johansson G. Lindstredt Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones Fertil Steril 57 1992 505
32. P.O. Dale T. Tanbo S. Vaaler Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovary syndrome: Evidence of two distinct populations Fertil Steril 58 1992 487
33. T.L. Daniels S.L. Berga Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation J Clin Endocrinol Metab 82 1997 4179
34. F. Darendeliler F. Bas S. Balaban Spironolactone therapy in hypertrichosis Eur J Endocrinol 135 1996 604
35. Del Gaudio A. Del Gaudio G.A. Virilizing adrenocortical tumors in adult women: Report of 10 patients, 2 of whom each had a tumor secreting only testosterone Cancer 72 1993 1997
36. J. Derksen S.K. Nagesser A.E. Meinders Identification of virilizing adrenal tumors in hirsute women N Engl J Med 331 1994 968
37. G.W. DeVane N.M. Czekala H.L. Judd Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease Am J Obstet Gynecol 121 1975 496
38. A. Dunaif Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome? J Clin Endocrinol Metab 63 1986 215
39. A. Dunaif Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non–insulin-dependent diabetes mellitus Am J Med 98 suppl 1A 1995 33S
40. A. Dunaif J. Mandeli H. Fluhr The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome J Clin Endocrinol Metab 66 1989 131
41. A. Dunaif D. Scott D. Finegood The insulin-sensitizing agent troglitazone improves the metabolic and reproductive abnormalities in the polycystic ovary syndrome J Clin Endocrinol Metab 81 1996 3299
42. A. Dunaif K.R. Segal W. Futterweit Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165
43. A. Dunaif J. Xia C.B. Book Excessive insulin receptor serine phosphorylation in cultured fibroblasts in skeletal muscle: A potential mechanism for insulin resistance in the polycystic ovary syndrome J Clin Invest 96 1995 801
44. D.A. Ehrmann M.K. Cavaghan J. Imperial Effects of metformin on insulin secretion, insulin action and steroidogenesis J Clin Endocrinol Metab 82 1997 524
45. D.A. Ehrmann R.L. Rosenfield R. Barnes Detection of functional ovarian hyperandrogenism in women with androgen excess N Engl J Med 327 1992 157
46. D.A. Erhmann D.J. Schneider B.E. Sobel Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome J Clin Endocrinol Metab 82 1997 2108
47. D.A. Ehrmann J. Sturis M.M. Byrne Insulin secretory defects in polycystic ovary syndrome: Relationship to insulin secretion and family history of non–insulin-dependent diabetes mellitus J Clin Invest 96 1995 520
48. G.F. Erickson D.A. Magoffin C.A. Dyer The ovarian androgen-producing cells: A review of structure/function relationships Endocr Rev 6 1985 371
49. D. Ferriman J.D. Gallwey Clinical assessment of body hair growth in women J Clin Endocrinol Metab 21 1961 1440
50. M. Filicori J.P. Butler Crowley W.F. Jr Neuroendocrine regulation of the corpus luteum in the human: Evidence for pulsatile progesterone secretion J Clin Invest 73 1984 1638
51. M. Filicori C. Flamigni Crowley W.F. Jr The critical role of blood sampling frequency in the estimation of episodic luteinizing hormone secretion in normal women Crowley W.F. Jr Hofler J.G. The Episodic Secretion of Hormones 1987 John Wiley & Sons New York 5 13
52. C.I. Friedman G.E. Schmidt M.H. Kim Serum testosterone concentrations in the evaluation of androgen-producing tumors Am J Obstet Gynecol 153 1985 44
53. R.D. Gambrell R.B. Greenblatt V.B. Mahesh Inappropriate secretion of LH in the Stein-Leventhal syndrome Obstet Gynecol 42 1973 429
54. C. Gilling-Smith H. Story V. Rogers Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome Clin Endocrinol 47 1997 93
55. L.R. Granger S. Roy D.R. Mishell Changes in unbound sex steroids and sex hormone binding globulin-binding capacity during oral and vaginal preestrogen administration Am J Obstet Gynecol 144 1982 578
56. H. Grulet A.C. Hecart B. Delemer Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome Clin Endocrinol 38 1993 621
57. D.S. Guzick E.O. Talbott K. Sutton-Tyrrell Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study Am J Obstet Gynecol 174 1996 1224 1232
58. W.M. Hague J. Adams C. Rodda The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives Clin Endocrinol 33 1990 501
59. J.E. Hall A.E. Taylor K.A. Martin Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women Proc Natl Acad Sci USA 91 1994 6894
60. J.E. Hall A.E. Taylor Martin K.A. Crowley W.F. Jr Neuroendocrine investigation of polycystic ovary syndrome: New approaches. Chap. 4 Dunaif A. Givens J.R. Haseltine F.P. Merriam G.R. Polycystic Ovary Syndrome Current Issues in Endocrinology and Metabolism 1992 Blackwell Scientific Boston
61. J. Hammerstein Possibilities and limits of endocrine therapy Hammerstein J. Lachnit-Fixson U. Neumann F. Plewig G. Androgenization in Women 1980 Excerpta Medica Amsterdam 221
62. M.G. Hammond Monitoring techniques for improved pregnancy rates during clomiphene ovulation induction Fertil Steril 42 1984 499
63. R. Hatch R.S. Rosenfield M.H. Kim Hirsutism: Implications, etiology, and management Am J Obstet Gynecol 140 1981 815
64. F.J. Hayes A.E. Taylor K.A. Martin Use of a GnRH antagonist as a physiologic probe in polycystic ovary syndrome: Assessment of the neuroendocrine and androgen dynamics J Clin Endocrinol Metab 83 1998 2343 2349
65. J. Holte T. Bergh C. Berne Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance J Clin Endocrinol Metab 78 1994 1052
66. R. Horton D. Hawks R. Lobo 3-Alpha, 17-beta-androstanediol glucuronide in plasma: A marker of androgen action in idiopathic hirsutism J Clin Invest 69 1982 1203
67. L. Ibanez J.E. Hall N. Potau Ovarian 17-hydroxyprogesterone hyperresponsiveness to GnRH agonist challenge in women with polycystic ovary syndrome is not mediated by LH hypersecretion: Evidence from GnRH agonist and human chorionic gonadotropin stimulation testing J Clin Endocrinol Metab 81 1996 4103
68. V. Imse G. Holzapfel B. Hinney Comparison of luteinizing hormone pulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays J Clin Endocrinol Metab 74 1992 1053
69. C.R. Kahn J.S. Flier R.S. Bar The syndromes of insulin resistance and acanthosis nigricans: Insulin receptor disorders in man N Engl J Med 294 1976 739
70. R.R. Kazer B. Kessel S.S.C. Yen Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome J Clin Endocrinol Metab 65 1987 233
71. W.C. Keetel J.T. Bradbury F.J. Stoddard Observations on the polycystic ovary syndrome Am J Obstet Gynecol 73 1957 954
72. A.C. Kelly R. Jewelewicz Alternate regimens for ovulation induction in polycystic ovarian disease Fertil Steril 54 1990 195
73. D.S. Kiddy D. Hamilton-Fairley A. Bush Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome Clin Endocrinol (Oxf) 36 1992 105
74. D.S. Kiddy P.S. Sharp D.M. White Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases Clin Endocrinol 32 1990 213
75. M.A. Kirschner E. Samojlik D. Silber A comparison of androgen production and clearance in hirsute and obese women J Steroid Biochem 19 1983 607
76. O.A. Kletzky V. Davajan R.M. Nakamura Classification of secondary amenorrhea based on distinct hormonal patterns J Clin Endocrinol Metab 41 1975 660
77. T. Laatikainen A. Tulenheimo B. Andersson Obesity, serum steroid levels, and pulsatile gonadotropin secretion in polycystic ovarian disease Eur J Obstet Gynecol Reprod Biol 15 1983 45
78. G. Lambert-Messerlian A. Taylor L. Leykin Characterization of intrafollicular steroid hormones, inhibin, and follistatin in women with and without polycystic ovary syndrome following gonadotropin hyperstimulation Biol Reprod 57 1997 1211
79. R.A. Lobo O.A. Kletzky J.D. Campeau Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome Fertil Steril 39 1983 674
80. R.A. Lobo D. Shoupe P. Serafini The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women Fertil Steril 43 1985 200
81. C. Longcope Adrenal and gonadal androgen secretion in normal females Endocrinol Metab Clin North Am 15 1986 213
82. J.D. Madden L. Milewich C.R. Parker The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate Am J Obstet Gynecol 132 1978 380
83. H.D. Mason D.S. Willis R.W. Beard Estradiol production by granulosa cells of normal and polycystic ovaries: Relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid J Clin Endocrinol Metab 79 1994 1355
84. J.W. McArthur F.M. Ingersoll J. Worcester The urinary excretion of interstitial cell and follicle-stimulating hormone activity by women with diseases of the reproductive system J Clin Endocrinol Metab 18 1958 1202
85. D.R. Meldrum G.E. Abraham Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors Obstet Gynecol 53 1979 36
86. P. Moghetti R. Castello C. Negri Flutamide in the treatment of hirsutism: Long-term clinical effects, endocrine changes, and androgen receptor behavior Fertil Steril 64 1995 511
87. Molloy B.G. El Sheikh M.A.A. C. Chapman Pathological mechanisms in polycystic ovary syndrome: Modulation of LH pulsatility by progesterone Br J Obstet Gynecol 91 1984 457
88. A.J. Morales G.A. Laughlin T. Butzow Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: Common and distinct features J Clin Endocrinol Metab 81 1996 2854
89. C.P. Moxham V. Duronio S. Jacobs Insulin-like growth factor I receptor beta-subunit heterogeneity: Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers J Biol Chem 264 1989 13238
90. J.E. Nestler D.J. Jakubowicz Decreases in ovarian cytochrome P450c17-alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome N Engl J Med 335 1996 617
91. J.E. Nestler D.J. Jakubowicz Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17α activity and serum androgens J Clin Endocrinol Metab 81 1997 4075
92. J.E. Nestler D.J. Jakubowicz de Vargas A.F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system J Clin Endocrinol Metab 83 1998 2001 2005
93. J.E. Nestler C.O. Barlascini D.W. Matt Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome J Clin Endocrinol Metab 68 1989 1027
94. J.E. Nestler L.P. Powers D.W. Matt A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with polycystic ovary syndrome J Clin Endocrinol Metab 72 1991 83
95. M.I. New F. Lorenzen A.J. Lerner Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data J Clin Endocrinol Metab 57 1983 320
96. J.B. O'Driscoll H. Mamtora J. Higginson A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia Clin Endocrinol (Oxf) 41 1994 231
97. R. Paradisi S. Venturoli R. Pasquali Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease J Endocrinol Invest 9 1986 139
98. R. Pasquali D. Antenucci F. Casimirri Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss J Clin Endocrinol Metab 68 1989 173
99. R. Pasquali F. Casimirri S. Venturoli Insulin resistance in patients with polycystic ovaries: Its relationship to body weight and androgen levels Acta Endocrinol (Copenh) 104 1983 110
100. C.L. Pastor M.L. Griffen-Korf J.A. Aloi Polycystic ovary syndrome: Evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone J Clin Endocrinol Metab 83 1998 582
101. A.N. Peiris E.J. Aiman W.D. Drucker The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women J Clin Endocrinol Metab 68 1989 715
102. D.E. Pittaway W.S. Maxson A.C. Wentz Spironolactone in combination drug therapy for unresponsive hirsutism Fertil Steril 43 1985 878
103. L. Poretsky F. Grigorescu M. Seibel Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary J Clin Endocrinol Metab 61 1985 728
104. D.W. Polson J. Wadsworth J. Adams Polycystic ovaries—a common finding in normal women Lancet 1 1988 870
105. R. Rebar H.L. Judd S.S.C. Yen Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome J Clin Invest 57 1976 1320
106. K.A. Risma C.M. Clay T.M. Nett Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors Proc Natl Acad Sci USA 92 1995 1322
107. R.S. Rittmaster Medical treatment of androgen-dependent hirsutism J Clin Endocrinol Metab 80 1995 2559
108. W.G. Rossmanith J. Keckstein K. Spatsier The impact of ovarian laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease Clin Endocrinol (Oxf) 34 1991 223
109. H.E. Scaglia M. Medina C. Gual The Stein-Leventhal syndrome: A neuropituitary disorder? Fertil Steril 27 1976 243
110. S. Smith V.A. Ravnikar R.L. Barbieri Androgen and insulin response to an oral glucose challenge in hyperandrogenic women Fertil Steril 48 1987 72
111. L.R. Sorbara Z. Tang A. Cama Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome Metabolism 43 1994 1568
112. T. Spinder J.J. Spijkstra L.J.G. Gooren Effects of long-term testosterone administration on gonadotropin secretion in agonadal female to male transsexuals compared with hypogonadal and normal women J Clin Endocrinol Metab 68 1989 200
113. T. Spinder J.J. Spijkstra van den Tweel J.G. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in rugonadal female to male transsexual subjects J Clin Endocrinol Metab 69 1989 151
114. D.I. Spratt J.S. Finkelstein J.P. Butler Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men J Clin Endocrinol Metab 64 1987 1179
115. P. Spritzer L. Billaud Thalabard J.-C. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia J Clin Endocrinol Metab 70 1990 642
116. I. Stein M. Leventhal Amenorrhea associated with bilateral polycystic ovaries Am J Obstet Gynecol 29 1935 181
117. G.E. Tagatz R.A. Kopher T.C. Nagel The clitoral index: A bioassay of androgenic stimulation Obstet Gynecol 54 1979 562
118. J.A. Talbot E.J. Bicknell M. Rajkhowa Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome J Clin Endocrinol Metab 81 1996 1979
119. A.E. Taylor B. McCourt E.J. Anderson Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome J Clin Endocrinol Metab 82 1997 2248
120. M.L. Taymor R. Barnard Luteinizing hormone excretion in the polycystic ovary syndrome Fertil Steril 13 1962 501
121. E.M. Velazquez S. Mendoza T. Hamer Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy Metabolism 43 1994 647
122. I. Vermes H.A. Bonte Sluijs Veer G.V.D. Interpretations of five monoclonal immunoassays of lutropin and follitropin: Effects of normalization with WHO standard Clin Chem 37 1991 415
123. M. Vermesh P.D. Silva G.F. Rosen Effect of androgen on adrenal steroidogenesis in normal women J Clin Endocrinol Metab 66 1988 128
124. P. Vexiau B. Gueux D. Vexiau-Robert Metabolic effects of combined cyproterone acetate and percutaneous 17 beta oestradiol after six and twelve months therapy in 61 patients Horm Metab Res 20 1988 765
125. J. Waldstreicher N.F. Santoro J.E. Hall Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: Indirect evidence for partial gonadotroph desensitization J Clin Endocrinol Metab 66 1988 165
126. A.C. Wentz G.S. Jones K. Sapp Pulsatile gonadotropin output in menstrual dysfunction Obstet Gynecol 47 1976 309
127. R.A. Wild B. Grubb A. Hartz Clinical signs of androgen excess as risk factors for coronary artery disease Fertil Steril 54 1990 255
128. D. Willis S. Franks Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor J Clin Endocrinol Metab 80 1995 3788
129. I.L. Wong R.S. Morris L. Chang A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women J Clin Endocrinol Metab 80 1995 233
130. D.K. Wysowski J.P. Freiman J.B. Tourtelot Fatal and nonfatal hepatotoxicity associated with flutamide Ann Intern Med 119 1993 1150
131. S.S.C. Yen The polycystic ovary syndrome Clin Endocrinol 12 1980 177
132. S.S.C. Yen P. Vela J. Rankin Inappropriate secretion of follicle stimulating hormone and luteinizing hormone in polycystic ovarian disease J Clin Endocrinol Metab 30 1970 435
133. J.K. Zawadzki A. Dunaif Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach Dunaif A. Givens J.R. Haseltine F.P. Merriam G.R. Polycystic Ovary Syndrome. Current Issues in Endocrinology and Metabolism vol 4 1992 Blackwell Scientific Boston
134. Zhang L.-H. H. Rodriguez S. Ohno Serine phosphorylation of human P450c17 increases 17,20-lyase activity: Implications for adrenarche and the polycystic ovary syndrome Proc Natl Acad Sci USA 92 1995 10619
135. B. Zumoff R.S. Rosenfield G.W. Strain Sex differences in the twenty-four-hour mean plasma concentrations of dehydroepiandrosterone (DHA) and dehydroepiandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults J Clin Endocrinol Metab 51 1980 330